Forest Investigative Site 257 — Fort Mill, South Carolina

Forest Investigative Site 257 is a clinical research site located in Fort Mill, South Carolina, United States 29707.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Forest Investigative Site 257 has participated in 1 clinical trials.

Therapeutic areas: COPD, COPD Exacerbation, Lung Diseases.

Sponsors: AstraZeneca.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fort Mill

Browse all research sites in South Carolina · View every site in Fort Mill

• Piedmont Research Partners
• GSK Investigational Site
• Research Site
• Novartis Investigative Site
• Forest Investigative Site 1914
• Arthrosi Investigative Site (604)
• Chiesi Clinical Trial Site 840211
• Nichi-Iko Investigational Site
• Chiesi Investigational Site
• Shiland Family Practice
• Investigational Site Number 8408060
• 205.479.01026 Boehringer Ingelheim Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Forest Investigative Site 257?

Forest Investigative Site 257 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Forest Investigative Site 257 conducted?

Forest Investigative Site 257 has 1 clinical trials on record. Their work covers COPD, COPD Exacerbation, Lung Diseases.

Is Forest Investigative Site 257 accredited by Crixeo Clinical Trials?

Forest Investigative Site 257 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Forest Investigative Site 257?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.